Stay updated on Lanadelumab for Pediatric HAE Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.

Latest updates to the Lanadelumab for Pediatric HAE Attacks Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry (v3.6.4) appears in the study record history, updating the version from v3.6.3. This reflects an administrative update to the record’s revision metadata.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision, v3.6.3, was added, replacing the previous v3.6.2. This reflects an update to the page's record history.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision label v3.6.2 has been added to the record history, replacing the older v3.6.0 entry. This reflects an updated site release in the page's version history.SummaryDifference0.1%

- Check57 days agoChange DetectedThe history now indicates recruitment has closed (no longer looking for participants). A new revision tag v3.6.0 was added and the previous revision tag v3.5.5 was removed.SummaryDifference0.4%

- Check64 days agoChange DetectedThe history now lists Revision: v3.5.5, replacing the previous v3.5.4. This marks a new revision of the page's documentation within ClinicalTrials.gov.SummaryDifference0.1%

- Check85 days agoChange DetectedThe history updates to include a new site revision, v3.5.4, while the previous revision, v3.5.3, is removed from the record. This reflects a version bump in the site's release notes.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab for Pediatric HAE Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.